Efficacy of substance P and insulin-like growth factor-1 peptides for preventing postsurgical superficial punctate keratopathy in diabetic patients

Japanese Journal of Ophthalmology

Volumn 53, Issue 5, 2009, Pages 464-469

  Chikamoto, Nobuhiko ^a   Chikama, Tai Ichiro ^a   Yamada, Naoyuki ^a   Nishida, Teruo ^a   Ishimitsu, Tadashi ^b   Kamiya, Akira ^b  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cataract surgery; Corneal epithelium; Diabetic keratopathy; Peptides; Superficial punctate keratopathy

Indexed keywords

BETAMETHASONE; DICLOFENAC; EYE DROPS; FLUOROMETHOLONE; LEVOFLOXACIN; OFLOXACIN; SOMATOMEDIN C; SUBSTANCE P;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CATARACT EXTRACTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; CORNEA EPITHELIUM; DOUBLE BLIND PROCEDURE; DRUG SUBSTITUTION; DRY EYE; FEMALE; HUMAN; KERATOPATHY; LACRIMATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHACOEMULSIFICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SUPERFICIAL PUNCTATE KERATOPATHY;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; CORNEAL DISEASES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; EPITHELIUM, CORNEAL; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OLIGOPEPTIDES; OPHTHALMIC SOLUTIONS; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SUBSTANCE P; TREATMENT OUTCOME;

EID: 77749286438     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-009-0693-4     Document Type: Article

References (26)

1. G.F. Cahill Jr L.D. Etzwiler N. Freinkel 1976 "Control" and diabetes N Engl J Med 294 1004 1005 1256496
2. The Diabetes ControlComplications Trial Research Group. 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 977 986 10.1056/NEJM199309303291401 (Pubitemid 23307905)
3. R.O. Schultz M.A. Peters K. Sobocinski, et al. 1983 Diabetic keratopathy as a manifestation of peripheral neuropathy Am J Ophthalmol 96 368 371 1:STN:280:DyaL3szgsF2rsg%3D%3D 6311017
4. M. Gobbels M. Spitznas J. Oldendoerp 1989 Impairment of corneal epithelial barrier function in diabetics Graefes Arch Clin Exp Ophthalmol 227 142 144 10.1007/BF02169787 1:STN:280:DyaL1M3lt12ntQ%3D%3D 2721983 (Pubitemid 19066680)
5. M. Goebbels M. Spitznas 1991 Endothelial barrier function after phacoemulsification: a comparison between diabetic and nondiabetic patients Graefes Arch Clin Exp Ophthalmol 229 254 257 10.1007/BF00167879 1:STN:280:DyaK3MzjtFegsQ%3D%3D 1869062
6. R.O. Schultz D.L. Van Horn M.A. Peters, et al. 1981 Diabetic keratopathy Trans Am Ophthalmol Soc 79 180 199 1:STN:280:DyaL383gtVOqtA%3D%3D 7342400
7. H.D. Perry G.N. Foulks R.A. Thoft, et al. 1978 Corneal complications after closed vitrectomy through the pars plana Arch Ophthalmol 96 1401 1403 1:STN:280:DyaE1c3jsVylsw%3D%3D 678179
8. J.G. Daubs 1975 Diabetes screening with corneal aesthesiometer Am J Optom Physiol Opt 52 31 35 1:STN:280:DyaE2M%2FovVOjuw%3D%3D 1111287
9. J. Saito M. Enoki M. Hara, et al. 2003 Correlation of corneal sensation, but not of basal or reflex tear secretion, with the stage of diabetic retinopathy Cornea 22 15 18 10.1097/00003226-200301000-00004 12502941 (Pubitemid 36076675)
10. T. Nishida M. Nakamura K. Ofuji, et al. 1996 Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea J Cell Physiol 169 159 166 10.1002/(SICI)1097-4652(199610)169:1<159:: AID-JCP16>3.0.CO;2-8 1:CAS:528:DyaK28XmtFClu7s%3D 8841432 (Pubitemid 26342525)
11. M. Nakamura K. Ofuji T. Chikama T. Nishida 1997 Combined effects of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbit in vivo Curr Eye Res 16 275 278 10.1076/ceyr.16.3.275.15409 1:STN:280:DyaK2s3ktl2jtw%3D%3D 9088746 (Pubitemid 27129973)
12. T. Nagano M. Nakamura K. Nakata, et al. 2003 Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy Invest Ophthalmol Vis Sci 44 3810 3815 10.1167/iovs.03-0189 12939296 (Pubitemid 37047950)
13. T. Nishida T. Chikama N. Morishige, et al. 2007 Persistent epithelial defects due to neurotrophic keratopathy treated with a substance P-derived peptide and insulin-like growth factor 1 Jpn J Ophthalmol 51 442 447 10.1007/s10384-007-0480-z 1:CAS:528:DC%2BD1cXlt1Cgsr0%3D 18158595
14. N. Yamada R. Matsuda N. Morishige, et al. 2008 Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy Br J Ophthalmol 92 896 900 10.1136/bjo.2007.130013 1:STN:280:DC%2BD1cvgs1alug%3D%3D 18511539 (Pubitemid 351969664)
15. K. Miyata S. Amano M. Sawa, et al. 2003 A novel grading method for superficial punctate keratopathy magnitude and its correlation with corneal epithelial permeability Arch Ophthalmol 121 1537 1539 10.1001/archopht.121.11. 1537 14609908 (Pubitemid 37392355)
16. T. Nishida S. Nakagawa T. Awata, et al. 1983 Fibronectin promotes epithelial migration of cultured rabbit cornea in situ J Cell Biol 97 1653 1657 10.1083/jcb.97.5.1653 1:STN:280:DyaL2c%2Fjt1Kruw%3D%3D 6415071
17. T. Nishida M. Nakamura H. Mishima, et al. 1991 Hyaluronan stimulates corneal epithelial migration Exp Eye Res 53 753 758 10.1016/0014-4835(91)90110-Z 1:CAS:528:DyaK38XjvVOjug%3D%3D 1783012
18. T. Chikama K. Fukuda N. Morishige, et al. 1998 Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I Lancet 351 1783 1784 10.1016/S0140-6736(98)24024-4 1:STN:280: DyaK1c3pslyktA%3D%3D 9635953 (Pubitemid 28269191)
19. N. Morishige T. Komatsubara T. Chikama, et al. 1999 Direct observation of corneal nerve fibres in neurotrophic keratopathy by confocal biomicroscopy Lancet 354 1613 1614 10.1016/S0140-6736(99)04198-7 1:STN:280: DC%2BD3c%2Fitlegug%3D%3D 10560682 (Pubitemid 29515959)
20. Kenyon KR, Chaves HV. Morphology and pathologic response of corneal and conjunctival disease. In: Smolin G, Thoft R, editors. The cornea, 3rd ed. Boston: Little, Brown; 1994. p. 73-75.
21. D.E. Schwartz 1974 Corneal sensitivity in diabetics Arch Ophthalmol 91 174 178 1:STN:280:DyaE2c7htValtw%3D%3D 4814962
22. M. Goebbels 2000 Tear secretion and tear film function in insulin dependent diabetics Br J Ophthalmol 84 19 21 10.1136/bjo.84.1.19 1:STN:280:DC%2BD3c%2FnvV2msw%3D%3D 10611093 (Pubitemid 30251627)
23. D.T. Azar S.J. Spurr-Michaud A.S. Tisdale, et al. 1992 Altered epithelialbasement membrane interactions in diabetic corneas Arch Ophthalmol 110 537 540 1:STN:280:DyaK383it1ChtQ%3D%3D 1532888
24. N. Morishige T.I. Chikama Y. Sassa, et al. 2001 Abnormal light scattering detected by confocal biomicroscopy at the corneal epithelial basement membrane of subjects with type II diabetes Diabetologia 44 340 345 10.1007/s001250051624 1:STN:280:DC%2BD3Mvntleruw%3D%3D 11317666 (Pubitemid 32234461)
25. N. Takahashi M. Wakuta N. Morishige, et al. 2007 Development of an instrument for measurement of light scattering at the corneal epithelial basement membrane in diabetic patients Jpn J Ophthalmol 51 185 190 10.1007/s10384-007-0427-4 17554480 (Pubitemid 46889501)
26. Y. Kaji T. Usui T. Oshika, et al. 2000 Advanced glycation end products in diabetic corneas Invest Ophthalmol Vis Sci 41 362 368 1:STN:280: DC%2BD3c7jtl2hsQ%3D%3D 10670463